Checkpoint Capital L.P. Portfolio Holdings
Checkpoint Capital L.P.
- $150 Billion
- Q1 2024
Checkpoint Capital L.P. has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $150 Billion distributed in 17 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Rhythm Pharmaceuticals, Inc. with a value of $35.8B, Argenx Se with a value of $32.3B, Cytokinetics Inc with a value of $13.3B, Avadel Pharmaceuticals PLC with a value of $11.8B, and Axsome Therapeutics, Inc. with a value of $10.6B.
Examining the 13F form we can see an decrease of $15.5B in the current position value, from $165B to 150B.
Checkpoint Capital L.P. is based out at San Francisco, CA
Below you can find more details about Checkpoint Capital L.P. portfolio as well as his latest detailed transactions.